Christine Farrell
Director of Finance/CFO at ODYSSEY HEALTH, INC.
Net worth: 50 772 $ as of 30/04/2024
Profile
Christine M.
Farrell is currently the Chief Financial Officer & Secretary at Odyssey Health, Inc. She previously worked as the Vice President-Finance & Administration at Bioject Medical Technologies, Inc. from 1997 to 2014.
She completed her undergraduate degree at the University of Washington and holds an MBA from Willamette University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ODYSSEY HEALTH, INC.
1.42% | 29/12/2023 | 1,372,222 ( 1.42% ) | 50 772 $ | 30/04/2024 |
Christine Farrell active positions
| Companies | Position | Start |
|---|---|---|
| ODYSSEY HEALTH, INC. | Director of Finance/CFO | 21/01/2021 |
Former positions of Christine Farrell
| Companies | Position | End |
|---|---|---|
| BIOJECT MEDICAL TECHNOLOGIES INC. | Director of Finance/CFO | 01/07/2014 |
Training of Christine Farrell
| University of Washington | Undergraduate Degree |
| Willamette University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ODYSSEY HEALTH, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Bioject Medical Technologies, Inc.
 Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Bioject Medical Technologies, Inc. develops and manufactures needle-free injection therapy systems. Its products include Biojector 2000, Needle Free Injection System, ZetaJet, Drug Reconstitution System, and Needle-Free Vial Adapter. The company was founded in 1985 and is headquartered in Tigard, OR. | Health Technology |
- Stock Market
- Insiders
- Christine Farrell
